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Highlights1
A long-acting moxidectin formulation (Cydectin® 2% LA, Zoetis) administered to ewes in three farms 2
reduced the excretion of gastrointestinal nematode (GIN) eggs by 56, 84 and 87% resp. compared 3
with untreated controls (p<0.05) in an Haemonchus contortus dominated environment.4
GIN egg shedding of untreated lambs grazing with moxidectin-treated ewes was reduced by 56% and 5
61%, resp. (p<0.05) mediated by the lower pasture contamination with GIN-larvae.6
Untreated lambs grazing with moxidectin-treated ewes exhibited a higher daily weight gain7
compared with lambs from untreated ewes (p<0.05).8
9
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Abstract20
A field study was undertaken on three Swiss sheep farms (A, B, C) to evaluate the efficacy of a long-21
acting moxidectin formulation (Cydectin® 2% LA) against gastrointestinal nematodes (GIN). Naturally 22
infected ewes (all three farms) and their winter-borne lambs (farms A and B) were allocated to two 23
groups (MOX, CON). At day 0 ewes of the MOX-groups were treated with 1mg moxidectin s.c. CON-24
and MOX-groups were grazed on separate pastures and were sampled for faeces and blood at 28-day 25
intervals. Larval cultures demonstrated that Haemonchus contortus was the dominant GIN-species in 26
ewes throughout the season. Over the entire observation period faecal egg count (FEC) of the MOX-27
ewes in farms A, B, C was 56, 84 and 87% less than the CON-ewes (p<0.05). FEC of lambs grazing with28
MOX-ewes was reduced in farms A and B by 56% and 61%, respectively (p<0.05), compared with the 29
respective CON-groups. None of these lambs received anthelmintic treatment during the 30
experiment. Therefore, the differences were due to an indirect effect mediated by the lower pasture 31
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contamination with GIN-larvae. These were reduced by 73, 81 and 74% in farms A-C respectively 32
compared to the CON-groups (p<0.05). In farm B, where lambs remained with their mothers during 33
the entire grazing season, these differences were also reflected by a higher daily weight gain (p<0.05)34
and reduced pepsinogen levels in lambs of treated ewes. This strategy offers an interesting potential 35
for expanding refugia by propagation of GIN in untreated lambs.36
Key words: Sheep; Moxidectin; Control; Gastrointestinal nematodes; Switzerland37
1. Introduction38
In Switzerland, as elsewhere, infections with gastrointestinal nematodes (GIN) are regarded as high 39
priority by sheep farmers. Virtually all farms are affected and the dominance of Haemonchus40
contortus prevailing in altitudes up to 1500m may result in life-threatening disease in all age groups 41
in the absence of adequate control measures. From May to September mean temperatures between 42
12 and 18°C and average monthly rainfall of 99 mm provide favourable conditions for development 43
and migration of infective larvae (O'Connor et al., 2006). Currently, helminth control is almost 44
entirely dependent on the use of anthelmintics. Usually, ewes and their spring-born lambs graze 45
together until late summer. Anthelmintic treatment is usually done either at fixed intervals, or when 46
indicated by monitoring of bulk faecal samples. For sheep kept on community pastures on which 47
regular access to the animals is often hampered there is an increasing demand by owners to perform 48
parasite control by long acting anthelmintics. In contrast to cattle, formulations providing a season-49
wide protection were not available for sheep in Europe until recently. Worldwide, only few long-50
acting products are registered for sheep. These include a controlled-release albendazole capsule 51
(Proftil-Captec, Merial) (Bell and Thomas, 1992; Munyua et al., 1997) or an ivermectin capsule 52
(IVOMEC maximize, Merial) (Gogolewski et al., 1997; Rehbein et al., 1998). Product indications 53
suggests a protection of sheep for 100 days from reinfection with gastrointestinal helminths (Bell and 54
Thomas, 1992; Rehbein et al., 1998) and are supposed to be a highly effective method of seasonal 55
parasite control. However, the use of these products is limited to Australia and New Zealand and 56
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many farmers are reluctant to use intraruminal capsules because of the risk of injury by poor 57
administration techniques (Macrae et al., 2003; Harwood and Hepple, 2011). The easy to handle 58
pour-on formulations are not suitable for sheep as wool and skin surfaces are coated with a lipophilic 59
emulsion of sweat and sebum. This layer can act as a solvent for chemicals and therefore diffusion of 60
a drug within the emulsion competes with the absorption into the skin and thus limits the systemic 61
availability (Pitman and Rostas, 1981; Rehbein, 1993; Magnusson et al., 2001; Baynes, 2004; 62
Monteiro-Riviere et al., 2008). For these reasons an injectable long-acting anthelmintic is desirable.63
Injectable ivermectin has a persistent activity for up to 10 days against reinfection with H. contortus 64
at a dosage of 0.2 mg/kg (Borgsteede, 1993). Likewise, moxidectin at a dosage of 0.2mg/kg protects 65
for up to 35 days from a reinfection with H. contortus and Teladorsagia circumcincta and 21 days 66
from Trichostrongylus colubriformis(Kerboeuf et al., 1995). 67
Recently, a new injectable long-acting formulation of moxidectin (Cydectin 2% LA, Zoetis, 68
Switzerland) was introduced to the market for meat sheep. For Switzerland, the manufacturer is 69
claiming a persistent activity against reinfection with H. contortus, T. circumcincta and T. 70
colubriformis for 111, 97 and 44 days, respectively.71
The aim of the present study was to evaluate the efficacy of a single administration of moxidectin at 72
a dose rate of 1mg/kg during one grazing season in three sheep farms in the Swiss midland region. In 73
two of these farms, it was investigated if treatment of the ewes may also provide indirect protection 74
of the untreated lambs. Furthermore, lambs could serve to maintain refugia (van Wyk, 2001) and 75
mitigate the expansion of resistant populations given that the resistance level is still low.76
2. Materials and methods77
2.1Experimental design78
The study was conducted on three privately owned farms in the Swiss midland region during the 79
2011 grazing season. Key data of the different sites are summarised in Table 1. All ewes had been 80
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naturally infected with helminths during the previous year and all farms were free from F. hepatica.81
On day 0, the adult sheep were randomly divided into 2 similar groups, in farm A and B based on the 82
number of their winter-born lambs. Sheep in Farm C are neither lactating nor pregnant on day 0.83
Moxidectin (Cydectin 2% LA, Zoetis Switzerland) was administered subcutaneously at the base of the 84
left ear according to the manufacturer’s recommendations to the adult sheep of one group on each 85
farm (MOX-A, MOX-B, MOX-C) at a dose rate of 1.0 mg/kg BW. Ewes of the control groups (CON-A, 86
CON-B, CON-C) and all lambs remained untreated. On the following days, the injection site was 87
investigated by the owner for observation of side effects.88
On each farm several smaller pastures were included in the trial. Each pasture was divided into two 89
equal paddocks, on which the groups grazed separately at equal stocking rates. Sheep were rotated 90
between the pastures according to the same schedule for both groups and did not receive any 91
supplement. All pastures had been grazed by sheep the previous year. Because of dry weather 92
conditions in the early season, all groups were offered a similar portion of additional grazing area in 93
June, which previously had been used for hay.94
According to the owners’ management, lambs on farms A and B were excluded from the trial at 2- 3 95
month of age for final indoor fattening with the exception of six lambs per group at farm A which 96
remained in the trial to assess the indirect effect of moxidectin application to the adults on their 97
offspring. In farms A and C, rams were kept together with the ewes to maintain breeding activities in 98
the flocks from day 0 onwards, whereas the ram in farm B was integrated at the beginning of August.99
The rams in farms A and B were moved several times between the groups and were therefore kept100
under repeated dosing with moxidectin LA. Additionally, the absence of helminth egg shedding was 101
controlled at monthly intervals. Parasitological data of the rams in farms A and B were not included 102
in any analysis. To simplify description of the results, adult sheep in farm C are also referred to as 103
ewes despite the included rams.-104
One adult MOX-sheep of Farm A died in September, due to unknown reason, not related to parasitic 105
infection. One CON-lamb of farm B disappeared at the end of June and was possibly killed by foxes. 106
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At the end of September, one clinical healthy ewe of the treated group on site C had to be removed 107
due to misbehaviour (constant bleating) which wasn’t accepted by the community living close to the 108
pastures.109
2.2 Samplings and Measurements110
All animals were examined and sampled on day 0 and then at 4-weekly intervals. The sheep were 111
clinically examined including an assessment of the colour of the eye mucosa using the FAMACHA 112
system (van Wyk and Bath, 2002) to determine the level of anaemia. The live weight of lambs at 113
every other sampling date was recorded. Blood samples were taken from the jugular vein for 114
determining the packed cell volume (PCV) in all animals and pepsinogen was additionally recorded in 115
lambs according to the method of Berghen et al.(1987). Faecal samples, directly collected from the 116
rectum, were scored for consistency (1: watery diarrhoea; 5: well-formed dry faeces) and numbers of 117
helminth eggs were determined quantitatively using a modified McMaster-technique(Schmidt, 1971)118
with a sensitivity of 50 eggs per gram (epg). Eggs other than strongyles were counted separately.119
Blood and faecal samples were chilled during transport and stored at 4 °C prior to processing. Third-120
stage larvae were cultured for each group separately according to Eckert(1960) and differentiated 121
according to the MAFF guidelines(Ministry of Agriculture, 1986). For the individual quantitative 122
diagnosis of lungworms, the Baermann-technique(Deplazes et al., 2012) was used. Results were 123
expressed as larvae per 10 g of faeces. Pasture contamination with infective larvae was determined 124
according to Sievers Prekehr(1973) modified by(Hertzberg et al., 1996).125
Individual animals were treated with monepantel at a dose rate of 2.5mg/kg BW (Zolvix, Novartis, 126
Switzerland) if their faecal egg count (FEC) exceeded 4000, PCV fell below 15 or when clinical signs of 127
helminthosis occurred. 128
2.3 Meteorology129
Mean 24h temperature (2m above ground level) and rainfall data were obtained from the national 130
weather service for the whole trial period. The nearest measuring points located on a similar altitude 131
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as the specific farms were chosen resulting in an aerial distance between 3 and 24km to the farms.132
Collected data were compared to the averaged values from 1961-1990.133
2.4 Faecal egg count reduction test and statistics134
Moxidectin susceptibility was tested with the faecal egg count reduction test (FECRT), based on the 135
recommendations of the World Association for the Advancement of Veterinary Parasitology (Coles, 136
1992) reviewed by Coles et al.(2006). A first series of FECRT was conducted in early April in animals 137
not participating in the study, a second series of FECRT was envisaged at the end of the experiment.138
The analyses of the FEC were done according to Torgerson et al.(2005; 2014). Remaining statistics 139
were calculated with SPSS Statistics 21 (IBM, Switzerland). Differences in PCV and weight gain were 140
analysed using Student’s t-test. The differences in pepsinogen values, FAMACHA, faecal consistency 141
and larval herbage counts were tested using the Wilcoxon signed rank test. Correlation between PCV 142
and FAMACHA scores were analysed using the Spearman rho-test. All measurements were regarded 143
as significant at a level p<0.05.144
3. Results145
Mean temperatures during the complete trial period were approximately 2 degrees Celsius higher 146
compared to the 30-year-average. Total precipitation was 54% of the 30-year-average on farms A147
and B (376mm versus 687mm) whereas on farm C, it was similar to the average (1222 mm versus 148
1230mm). April and May were particularly dry with only 16% and 43% average precipitation149
respectively. April on farm C had just 29% of average precipitation.150
Arithmetic mean strongyle egg counts of the ewes were similar for MOX- and CON-groups on each 151
farm before treatment (p> 0.05). Initial values were considerably higher on farms A and B with 953 152
and 1047 epg, respectively, compared with farm C (37 epg) (Fig. 1-3). Following treatment with long 153
acting moxidectin at day 0, mean FEC of MOX-A- and MOX-B-ewes decreased substantially and154
remained significantly lower compared to those of CON-A-ewes up to the beginning ofJuly (D84) and 155
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compared with CON-B for the whole trial period apart from D82 (p<0.05). FEC of CON-A- and CON-B-156
ewes decreased markedly in early June and July, respectively, and fluctuated at a low level until the 157
end of the trial. Over the whole season, FEC of MOX-A- and -B-ewes was 56 and 84% lower than of 158
CON-ewes (p<0.05). Mean epg of MOX-C-ewes were low up to August (D105) and peaked at 65 epg 159
on D189. In CON-C-ewes the mean FEC developed from very low levels to 490 epg on D189. 160
Differences between CON-C- and MOX-C-ewes were significant calculated over the complete trial 161
period with a reduction by 87% in MOX-ewes (p<0.05). FEC of MOX-A lambs remained below those of 162
CON-lambs up to D 168, the difference being significant on days 28, 56, 84, 112 and 168 (Fig. 1). On 163
farm B differences reached significance on D28 and D82 (p<0.05) (Fig. 2). Overall, FEC of MOX-A- and -164
B-lambs was reduced by 56% and 61%, respectively, compared to CON-lambs (p<0.05).165
Apart from trichostrongyles, eggs of Trichuris were found on all farms, of Capillaria on farm A, and of 166
Strongyloides on farms A and C. Such eggs were not observed in MOX-A- and MOX-C-ewes before167
September and never in MOX-B, whereas CON-ewes shed them over the whole trial period. In lambs, 168
shedding of Trichuris and Strongyloides eggs started simultaneously in spring. Overall, counts were 169
too low for statistical comparison.170
Results from serial coprocultures of adult sheep are summarized in Fig. 4-6. H. contortus was the 171
most abundant species in all groups until September, apart from CON-B and CON-C. In CON-B 172
Oesophagostomum/Chabertia and later Cooperia were predominant from June onwards. In CON-C173
Teladorsagia and then Trichostrongylus were predominant from June onwards. In MOX-A an 174
elevation of the H. contortus-specific FEC was first observed at D112. Teladorsagia and 175
Trichostrongylus reappeared first in July and beginning of August, respectively, and176
Oesophagostomum/Chabertia and Cooperia in late August. In lambs, the first three months were 177
dominated by infections with Teladorsagia in both experimental groups in farms A and B. Afterwards, 178
lambs of farm A showed no consistent pattern of development of larval genera, whereas H. contortus179
became predominant on farm B. An increase of Teladorsagia-specific FEC was seen at D 140, when a 180
mean value of 21 epg was found; until the end of the experiment these values remained below 60 181
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epg. While lungworm larvae were not detected in any faecal samples on farm C, protostrongyle-182
larvae were found in MOX- and CON-ewes of farms A and B before treatment. After treatment183
protostrongyle larvae were only detected in CON-A ewes on 6 out of 8 occasions and on every 184
sampling date in CON-B. Lungworm larvae were not found in MOX-ewes, resulting in a 100% 185
reduction compared to CON-ewes (p<0.05).186
Pepsinogen analysis in serum of both MOX-A- and CON-A-lambs revealed low levels around 300 mU187
tyrosine at day 0, differences being not significant (p > 0.05). Until the end of August (D140), the 188
mean pepsinogen levels of MOX-A-lambs remained below 500 mU tyrosine and subsequently189
increased exceeding a mean value of 2000mU. In late October and November levels remained above 190
those of CON-A (Fig. 7). Levels of this group rose steadily after day 0 and peaked at 1112 mU tyrosine191
in late August. Values of MOX-A-lambs were significantly lower on D 84, D 112 and D 140 (p<0.05), 192
whereas pepsinogen levels of MOX-A-lambs were higher on D 195 and D 224 compared with CON-A-193
lambs (p<0.05). At the end of the 8-week observation period of the lambs in farm B the mean194
pepsinogen levels in MOX-B-lambs were significantly lower (p<0.05) compared with those of CON-B-195
lambs (70 mU tyrosine versus 432 mU tyrosine).196
Mean daily weight gain of MOX-A-lambs measured over the 224 day observation period was 68g 197
versus 45g of CON-A-lambs: an increase of 51% (p<0.05). Based on a measuring period of 66 days the 198
average daily weight gain of MOX-B-lambs exceeded that of CON-B-lambs by 27% (159g versus 125g) 199
although this difference was not significant (p>0.05). Measurements of FAMACHA (Fig.8-10), PCV and200
faecal consistency score revealed a trend for more favourable values in the MOX-groups, but only201
faeces of ewes from farm C had a significantly drier consistency in moxidectin treated animals 202
compared to controls (CON 2.8 versus MOX 3.2, p<0.05). FAMACHA scores and PCV were negatively203
correlated (r=-0.59 in adults and r=-0.73 in lambs) (p<0.05).204
The seasonal development of pasture contamination with infective trichostrongyle larvae is shown in 205
Table 2. For the comparison of the experimental groups data were expressed as the mean larval 206
counts per kilogram dry matter (L3/kg DM) over the nine sampling dates. The values in MOX-A were 207
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260 versus 1114 in CON-A (p>0.05) and in MOX-B 161 L3/kg DM versus 865 in CON-B (p<0.05) and in 208
MOX-C 216 L3/kg DM versus 835 in CON-C (p>0.05), indicating a reduction of pasture larval counts 209
on the MOX-pastures by 73, 81 and 74% in farms A, B and C respectively. Overall, apart from D28 on 210
farm A and D49 on farm C, contamination of MOX-pastures was always below that of CON-pastures211
(Table 2).212
FECRT’s conducted in farms A and B in April exhibited a mean efficacy of 95% and 98% respectively. 213
On farm C the test could not be done due to a very low egg excretion. After housing the FECRT 214
performed in MOX-A-ewes showed a reduction rate of 98%, whereas due to low egg counts no 215
corresponding test was possible in farm B. In farm C the FECRT could only be performed in CON-ewes 216
and revealed a reduction of 80%.217
Three ewes and four lambs on farm A as well as one ewe on farm B, all belonging to the control 218
groups, had to be treated with anthelmintics because their FEC exceeded or PCV levels were less 219
than the predetermined values. No animals from the MOX-groups had to undergo therapeutic 220
treatment during the whole trial period. Clinical signs were seen once in a ewe of CON-B showing221
submandibular oedema. Adverse reactions to the moxidectin injection were not observed in any 222
sheep.223
224
4. Discussion225
The objective of this study was to investigate the efficacy of a long-acting formulation of moxidectin 226
in meat sheep in the Swiss midland region and to assess protection within a management system227
where only ewes and rams, but not lambs are treated. At day 0, mean FEC of ewes on farms A and B228
ranged between 800-1200 epg and were therefore adequately high for the purpose of this study. 229
After administration of moxidectin in mid-April, MOX-ewes of farms A and B exhibited the expected 230
decline in FEC to negligible levels and values remained low for the rest of the trial. FEC of CON-A- and 231
-B-ewes stayed high during the first weeks of the experiment before dropping markedly at the 232
beginning of July and June, respectively. Most likely, this drop in egg excretion in the untreated ewes233
Page 11 of 33
Ac
ce
pte
d M
an
us
cri
pt
11
was due to a self-cure phenomenon (Stoll, 1929; Gordon, 1948).This phenomenon is characterized by 234
a spontaneous expulsion of established adult nematodes and occurs when sensitized, grazing sheep 235
are suddenly exposed to high numbers of infective larvae on pasture. Induction of self-cure may 236
happen after heavy summer rainfall with following liberation of trapped infective larvae from faeces237
(Stewart, 1950; Allonby and Urquhart, 1975), a scenario which most likely was favoured by the238
unusual dry conditions in April and May and mean temperatures of two degrees Celsius above 239
average. As the ewes shed almost exclusively H. contortus eggs in spring, the sudden reinfection will 240
have been mostly caused by larvae of this species and such a situation induces elimination not only241
of H. contortus but also of other abomasal species as T. circumcincta, T. axei and T. colubriformis 242
(Kelly, 1973). However, the self-cure phenomenon provides no explanation for the constant low FEC 243
in CON-ewes for the rest of the trial. Despite the overall low FEC during the second part of the season244
MOX-A- and -B-ewes shed 56 and 84% less eggs than the respective CON-ewes.245
On farm A, the elevation of the H. contortus-specific FEC in MOX-ewes at D 112 is in accordance with 246
results of Papadopoulos et al.(2009). Matching results of the same study, the first evidence for an 247
increase of Teladorsagia-specific FEC was seen at D 140, however, as values remained below 100 epg 248
until the end of the experiment conclusions concerning efficacy of MOX during this period are 249
limited. MOX-ewes and -lambs in farms A and B showed a trend for higher PCV values (data not 250
shown) and lower FAMACHA scores, than CON-sheep suggesting a pathophysiological benefit of the 251
moxidectin treatment. According to low FEC in ewes on farm B in the second part of the season, the 252
efficacy of moxidectin, although significant for the total FEC, could not be analyzed for the different 253
genera or species during that period. Unlike the other farms, the non-lambing ewes on farm C254
entered the trial with a considerably lower FEC, which was probably due to an anthelmintic 255
treatment in the previous autumn. In contrast to the control group, the mean FEC of MOX-ewes did 256
not increase before late autumn. The overall reduction of the FEC of 87 % compared with the CON-257
ewes indicated a clear benefit of the MOX-treatment. On this farm faecal consistency in the CON-258
group was significantly reduced compared with the MOX-sheep due to the predominance of 259
Page 12 of 33
Ac
ce
pte
d M
an
us
cri
pt
12
Teladorsagia and Trichostrongylus, which in contrast to H. contortus are known as diarrhoea-inducing 260
species (Sargison, 2004).261
Based on the limited number of available sheep the GIN-populations on farms A and B were found to 262
be susceptible for moxidectin before the trial. After the experiment only in farm A 4 formerly 263
moxidectin LA-treated sheep were available for the FECRT which again revealed a mean reduction of 264
98% and therefore indicating no loss of efficacy throughout the experiment. In contrast, a mean of 265
80% efficacy was detected in CON-ewes of farm C after the experiment indicating the possible 266
presence of anthelmintic resistant nematodes. As these animals did not have contact to macrocyclic 267
lactones during the study, such resistant nematodes must have been present before the experiment, 268
when due to low egg counts the resistance status could not be investigated. Apparently, despite the 269
observed moderate reduction of efficacy of the 0.2 mg/kg formulation the long-acting formulation270
was able to control GIN efficiently throughout the trial period.271
Under regular meteorological conditions the egg output of ewes at the beginning of the season,272
deriving mainly from previously hypobiotic H. contortus, has a substantially higher impact on 273
subsequent infections than the overwintering pasture contamination, as H. contortus eggs and 274
especially infective larvae show poor capacity of surviving on pasture during winter (Gibson and 275
Everett, 1976; Jasmer et al., 1986; Jasmer et al., 1987). Although CON-ewes showed the highest FEC276
of H. contortus between April and June, CON-lambs shed hardly any Haemonchus-eggs, until July on 277
farm B and August on farm A. Most likely the lack of precipitation diminished the survival of eggs, 278
first and second stages of larvae of H. contortus and suppressed migration of infective larvae onto 279
herbage (Stromberg, 1997; O'Connor et al., 2007), which is mirrored by the low larval counts on 280
pastures in the first half of the season. In contrast, due to their higher capacity for overwintering 281
(O'Connor et al., 2006) infective larvae of Teladorsagia were most likely present on herbage in spring, 282
explaining the similar proportions of related infections in MOX- and CON-lambs during the first two 283
months on pasture. Increasing pepsinogen levels in serum are indicative for abomasal damage, 284
caused by Teladorsagia or H. contortus (Lawton et al., 1996; Simpson et al., 1997). Pepsinogen levels 285
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of MOX-A-lambs were significantly lower than the levels of CON-lambs during July and August and for 286
MOX-B-lambs in July, the final month on pasture for that group. Four weeks after day 0, pepsinogen 287
levels of CON-A-lambs rose to values close to 1000 mU, reflecting moderate abomasal infections. The 288
same level was not reached by the MOX-A-lambs until October indicating a prolonged protection289
compared with the controls. The reason for the increasing pepsinogen levels in MOX-A-lambs 290
between end of September and November remains unclear as these lambs experienced a lower 291
infection pressure compared with the controls. However, this rise was associated with an elevated 292
excretion of Haemonchus-eggs during October, being approximately five times higher compared with 293
the controls, which may explain the onset of the pepsinogen rise 2-3 weeks earlier. Under practical 294
conditions this rise would have had little impact, as most lambs are slaughtered by September. 295
However, regular faecal examinations should be performed in lambs which are kept untreated 296
alongside MOX-treated ewes and those which are used for stock replacement should receive an297
anthelmintic at the end of the season. Besides GIN low egg excretion of other nematodes, namely 298
Trichuris, Capillaria and Strongyloides was regularly detected in CON-ewes during the whole trial,299
whereas in MOX-ewes they appeared only in September and in l lower numbers than in CON-ewes. 300
Moxidectin at a dose rate of 0.2 mg/kg is known to be partially effective against Trichuris and 301
Strongyloides in sheep (Bauer and Conraths, 1994; Coles et al., 1994) and the findings of the present 302
study indicate that a dose rate of 1mg/kg may induce suppression of egg-shedding of these species303
for a period of 5 months. Furthermore, the long-acting formulation of moxidectin appears to be 304
effective against small lungworms as in contrast to the controls, larvae were not detected in faeces in 305
any MOX-treated ewes until termination of the study. These results are supported by findings of306
Papadopoulos et al. (2004) who demonstrated that moxidectin at a dose rate of 0.2 mg/kg is 307
effective against small lungworms.308
Determination of pasture larval contamination at D0 revealed overwintering of infective larvae in all 309
farms. Similar values were obtained for both groups in farms B and C, whereas results suggested 310
higher start values for the control group in farm A. As both experimental paddocks in this farm had 311
Page 14 of 33
Ac
ce
pte
d M
an
us
cri
pt
14
been used as a common pasture the year before, this result is not explainable by the grazing history312
and subsequent samplings revealed low contamination on pastures of both groups. As overwintering 313
of infective larvae is of no relevance with respect to Haemonchus contortus in the study region 314
(Hertzberg, unpublished observation), the egg excretion of the adult sheep will have played the 315
dominant role for perpetuating the infection. Despite the presence of untreated lambs the density of 316
GIN-larvae on the MOX-pastures was clearly reduced in farms A and B. MOX-lambs profited from this 317
situation and exhibited 56 and 61% lower FEC compared to CON-lambs in farms A and B respectively. 318
Comparable results were obtained by Sargison et al. (2012)in a study where T. circumcincta was the 319
dominating species. The different infection level with GIN was reflected in a significant (farm A) 320
higher daily weight gain in MOX-A-lambs which in contrast to farm B were kept on pasture until the 321
end of the experiment. As these lambs itself had received no anthelmintic treatment the differences 322
are entirely due to an indirect effect mediated by the lower pasture contamination. As the GIN-323
infections in the CON-ewes of farms A and B decreased unexpectedly, the results provide the 324
unexpected chance to selectively assess the impact of the period of high egg excretion after day 0 on 325
the overall development of infections in lambs uring the entire season. Therefore, the better 326
seasonal performance of the MOX-lambs can be almost entirely attributed to the significantly lower327
egg excretion of the MOX-ewes during a relatively short period in spring and early summer. As a 328
consequence it seems likely, that under usual conditions with persisting higher infections in the 329
untreated ewes the differences of the parasitological and pathophysiological parameters between 330
the lamb groups would have been even more pronounced. The fact that several CON-ewes and -331
lambs had to receive anthelmintic treatment also contributed to a less prominent divergence of the 332
performance between both groups and reflects the higher rate of costs and labour in the 333
unprotected animals.334
When introducing long-acting anthelmintic devices on the market, the consequences with respect to 335
selection of anthelmintic resistance have to be assessed thoroughly.336
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Due to slowly declining serum levels anthelmintics with persistent activity are held as an increased337
risk factor for the development of resistance compared to short-acting drugs (Smith et al., 1999). The 338
so-called tail-selection allows incoming larvae with a reduced susceptibility to the drug to establish 339
and reproduce under conditions of sub-therapeutic serum concentrations while susceptible 340
genotypes are eliminated.341
When comparing the serum levels of moxidectin after administration at a dose rate of 0.2mg/kg342
(recommended for moxidectin 0.1%) with those of 1mg/kg (recommended dose rate for long-acting 343
moxidectin), the terminal slope in both kinetics is more or less parallel, indicating that by using the 344
higher dose no prolonged exposure of the developing stages to sub-therapeutic levels occurs [R. 345
Prichard, personal communication]. Compared with repeated applications of the lower moxidectin346
dose the overall number of ‘tail-events’ will be reduced in the flock assuming a single application per 347
season per ewe as the recommended limit. Even a reduction of treatments below one per capita 348
seems realistic, as a certain number of more resilient ewes can be left untreated as they will benefit349
from a reduced pasture contamination. In a Haemonchus-dominated environment, as in the present 350
study the FAMACHA-scoring is a suitable approach for identification of anaemic individuals (van Wyk 351
and Bath, 2002; Kaplan et al., 2004). This was supported by the significant negative correlation 352
between FAMACHA scores and PCV in the present study.353
A long withdrawal period for meat, which in the case of Switzerland amounts to 104 days, and the 354
manufacturer’s restriction to use moxidectin LA in lambs weighing less than 15 kg, will exclude most 355
of the offspring which is scheduled for slaughter during the second part of the grazing season from 356
treatment with this formulation. The observation that lambs can be indirectly protected by the 357
reduced egg output of the ewes could mitigate this deficit. 358
When multiple treatments of both lambs and ewes can be replaced by a single treatment of the ewes359
with a long-acting product, this strategy would confine the risk for selection of resistant GIN to the 360
ewes. By reducing the number of ‘tail-events’ on the flock level this strategy may therefore offer an 361
interesting potential for expanding refugia. As a consequence of the relatively small farm sizes and 362
Page 16 of 33
Ac
ce
pte
d M
an
us
cri
pt
16
limited number of animals included in the present study further research is needed to support this 363
concept and to perform comparative studies with other established strategic control strategies.364
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Table 1:  484
Basic data on location, animals and treatments in the three experimental flocks485
Farm A Farm B Farm C
Geographic latitude and longitude 47°53' N/8°22' E 47°46' N/8°25' E 47°39' N/8°85' E
Height above sea level (m) 370 470 593
Sheep breed mixed meat breeds Shropshire Swiss White Alpine
Trial period 12 April- 22 Nov. 14 April-24 Nov. 26 April-1 Nov.
Date of administration of moxidectin LA 12 April 14 April 26 April
Number of ewes 10a/10b 7a/8b 11a/11b
Number of lambs 10a/8b (6a/6b)c 9a/6b, d -
Number of paddocks per group 8 4 4
a MOX group486
b CON group487
c number of lambs remaining in the trial until the end, (in brackets, only farm A)488
d lambs remained in the trial for only 3 months489
490
Table 2:491
Total number of infective third-stage trichostrongyle larvae per kg dried herbage on pastures492
Farm A Farm B Farm C
MOX CON MOX CON MOX CON
D0 12 April 0 1600 D0 14 April 124 119 D0 26 April 1134 1334
D28 10 May 41 28 D26 10 May 189 582 D21 17 May 51 135
D56 07 June 0 137 D54 07 June 49 452 D49 14 June 267 262
D84 05 July 22 78 D82 05 July 37 67 D77 12 July 0 199
D112 02 Aug. 36 692 D111 03 Aug. 82 540 D105 09 Aug. 0 68
D140 30 Aug. 59 146 D138 30 Aug. 58 227 D133 06 Sept. 15 38
D168 27 Sept. 485 694 D166 27 Sept. 310 1829 D161 04 Oct. 189 4398
D195 24 Oct. 443 713 D194 25 Oct. 203 942 D189 01 Nov. 70 248
D224 22 Nov. 1252 5938 D224 24 Nov. 392 3029
493
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493
Caption:494
495
Figure 1-3: Mean faecal trichostrongyle egg counts of ewes and lambs496
: each symbol represents a salvage treatment497
#: differences between MOX and CON significant (p<0.05)498
1: farm A a) lambs499
b) ewes500
2: farm B a) lambs501
b) ewes502
3: farm C503
504
Figure 4-6: Differentiation of trichostrongyle third-stage-larvae in coprocultures on the group level505
4: farm A a) lambs506
b) ewes507
5: farm B a) lambs508
b) ewes509
6: farm C510
511
Figure 7: Mean serum pepsinogen values of lambs on farm A512
#: differences between MOX- and CON-lambs significant (p<0.05)513
514
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Figure 8-10: Mean FAMACHA scores of ewes and lambs515
8: farm A516
9: farm B517
10: farm C518
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